Keyphrases
Indonesia
100%
COVID-19
97%
Tuberculosis Patients
74%
Multidrug-resistant Tuberculosis (MDR-TB)
63%
Surabaya
62%
Pulmonary Tuberculosis
51%
Tuberculosis
37%
COVID-19 Patients
32%
Sargassum
31%
Meta-analysis
28%
Seaweed
27%
Mycobacterium Tuberculosis (M. tb)
26%
Bedaquiline
22%
Indonesian
19%
Sputum
19%
Asthma
19%
Risk Factors
19%
Systematic Meta-analysis
19%
Healthcare Workers
18%
Acid-fast Bacilli
18%
Community-acquired Pneumonia
18%
TB Patients
18%
East Java Indonesia
17%
Chronic Obstructive Pulmonary Disease
16%
Idiopathic Pulmonary Fibrosis
15%
Eucheuma Cottonii
15%
Rifampicin
14%
Tuberculosis Treatment
13%
Sargassum Duplicatum
13%
Flour
13%
Core Needle Biopsy
13%
Hypertension
12%
Type 1 Diabetes Mellitus (T1DM)
12%
Interleukin-6
12%
Fucoxanthin
12%
Tertiary Referral Hospital
12%
Electronic Nose (E-nose)
12%
Delamanid
12%
Lung Tissue
11%
Chest X-ray
11%
Active Tuberculosis
11%
Alginate
11%
General Hospital
11%
QT Prolongation
11%
Comorbidity
11%
C-reactive Protein
11%
Disease Severity
10%
Medical Records
10%
Acute Respiratory Distress Syndrome
10%
Mortality Risk
10%
Carrageenan
10%
COVID-19 Vaccine
9%
Mortality Prediction
9%
Treatment Group
9%
Academic Hospital
9%
Diabetic Mice
9%
Rifampicin-resistant Tuberculosis
9%
Antioxidant Activity
9%
Severe Coronavirus Disease 2019
9%
Body Mass Index
9%
Antibody Response
9%
Modified Starch
9%
Commercial Feed
9%
Lopinavir
9%
Bruguiera Gymnorrhiza
9%
Gracilaria
9%
Caulerpa Racemosa
9%
Artemia Franciscana
9%
Growth Performance
9%
Shorter Regimen
9%
Artemia
8%
Intensive Phase
8%
Mortality Rate
8%
Survival Rate
8%
Completely Randomized Design
8%
Serum Levels
8%
Adverse Effects
8%
GeneXpert
8%
Pneumonia Patients
8%
QTc Interval
8%
Quantitative PCR
8%
Immune Response
8%
N-acetyltransferase 2 (NAT2)
8%
Breast Cancer
7%
No Significant Difference
7%
Anti-tuberculosis Drugs
7%
Quality of Life
7%
Inflammatory Cytokines
7%
Lung Cancer
7%
Hospitalized Patients
7%
Kappaphycus Alvarezii
7%
Antioxidant
7%
Tuberculosis Diagnosis
7%
Pulmonary Fibrosis
7%
Armpit
7%
Bronchodilator
7%
Salt Concentration
7%
Treatment Outcome
7%
Sputum Samples
7%
Immunohistochemistry
7%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
76%
Coronavirinae
53%
Lung Tuberculosis
45%
Drug Resistant Tuberculosis
33%
Infection
33%
Sargassum
27%
Diabetes Mellitus
25%
Bedaquiline
23%
Asthma
22%
Rifampicin
22%
Multi-Drug-Resistant Tuberculosis
22%
SARS Coronavirus
16%
Side Effect
16%
Chronic Obstructive Lung Disease
16%
Tumor Necrosis Factor
15%
Antioxidant
15%
Breast Cancer
15%
Community Acquired Pneumonia
15%
Tuberculosis
13%
Wound Healing
13%
Comorbidity
13%
Interleukin 6
13%
Mortality Rate
13%
COVID-19 Vaccine
13%
Prevalence
12%
Mycobacterium Tuberculosis
12%
Table Salt
12%
Delamanid
12%
Retrospective Study
11%
C Reactive Protein
11%
Acid Fast Bacterium
10%
Biological Marker
10%
Cross-Sectional Study
10%
Tuberculostatic Agent
9%
Non Small Cell Lung Cancer
9%
Okra
9%
Fibrosing Alveolitis
9%
Lopinavir Plus Ritonavir
9%
Alginic Acid
9%
Disease Severity
8%
Randomized Controlled Trial
8%
Inflammation
8%
Messenger RNA
8%
Bronchodilating Agent
8%
Antioxidant Capacity
7%
Isotopes of Potassium
7%
Moxifloxacin
7%
Lung Cancer
7%
Neoplasm
7%
Pharmacokinetics
7%
Adult Respiratory Distress Syndrome
7%
Wound
6%
Bagg Albino Mouse
6%
Cytokine
6%
Lung Fibrosis
6%
Cohort Study
6%
Quinolone Derivative
6%
Adenosine Deaminase
6%
Fucoxanthin
6%
Latent Tuberculosis
6%
Liver Injury
6%
Salbutamol
6%
Adenosine Receptor
6%
Aminophylline
6%
Electrolyte Disturbance
6%
Extrapulmonary Tuberculosis
6%
Combination Drug
6%
Hydroxychloroquine
6%
Helicobacter Pylori
6%
Lung Injury
6%
Gelatinase B
6%
Syndrome
6%
Staphylococcus Aureus
6%
Isoniazid
5%
Pharmacotherapy
5%
Antibiotics
5%
Infectious Agent
5%
Azithromycin
5%
IC50
5%
Atypical Mycobacterium
5%
Treatment Group
5%
Mycobacteria
5%
Medicine and Dentistry
COVID-19
78%
Lung Tuberculosis
32%
Sputum
26%
Diseases
22%
Infection
21%
Systematic Review
18%
Drug Resistant Tuberculosis
18%
Biopsy Technique
17%
Lung
15%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Multidrug Resistant Tuberculosis
14%
Meta-Analysis
13%
Acid Fast Bacterium
12%
Community-Acquired Pneumonia
12%
Bedaquiline
10%
Prevalence
10%
COVID-19 Vaccine
9%
Lung Tumor
9%
Asthma
9%
Sweat
9%
Chest Radiograph
8%
Cross Sectional Study
8%
Mycobacterium Tuberculosis
8%
Retrospective Study
7%
Immunohistochemistry
7%
Randomized Controlled Trial
7%
Tumor Necrosis Factor
7%
Interleukin 6
7%
Diabetes Mellitus
7%
Breast Cancer
7%
Extrapulmonary Tuberculosis
7%
Tuberculosis
7%
Mortality Rate
7%
Tuberculostatic Agent
7%
Patient Referral
6%
Mixed Infection
6%
Biological Marker
6%
Medical Record
6%
Malignant Neoplasm
6%
Idiopathic Pulmonary Fibrosis
6%
Rifampicin
6%
Non Small Cell Lung Cancer
6%
Antibody Response
6%
Liver Injury
6%
Acute Respiratory Distress Syndrome
6%
Non-Hodgkin Lymphoma
6%
Adenosine Deaminase
6%
Table Salt
6%
Helicobacter Pylori
6%
Delamanid
6%
Catenin
6%
Breast Carcinoma
6%
Diagnosis
5%
Lymphocyte
5%
Immune Response
5%
Adverse Effect
5%
Comorbidity
5%
COVID-19 Vaccination
5%